Bank of Montreal
TVGN icon

Bank of Montreal’s Tevogen Inc TVGN Stock Holding History

Bank of Montreal’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,714
Closed -$885K – 4254
2022
Q4 		$885K Sell
1,714
-2,770
-62% -$1.42M ﹤0.01% 2270
2022
Q3 		$2.28M Sell
4,484
-14,516
-76% -$7.32M ﹤0.01% 1745
2022
Q2 		$9.53M Sell
19,000
-6,400
-25% -$3.2M ﹤0.01% 1090
2022
Q1 		$12.7M Buy
+25,400
New +$12.6M 0.01% 1040

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal's TVGN Position: Q1 2023 in Review

Bank of Montreal sold out of Tevogen Inc (TVGN) in Q1 2023, closing a stake of 1,714 shares — an estimated $885K sold.

Bank of Montreal first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $12.7M in Q1 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • Bank of Montreal reported no remaining Tevogen Inc position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 1,714 Tevogen Inc shares in Q1 2023, an estimated $885K.
  • Bank of Montreal first reported a position in Tevogen Inc in Q1 2022 and held it in 4 quarters.
  • Bank of Montreal's Tevogen Inc position peaked at $12.7M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Inc as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.